Victoza (liraglutide)

**Product type:** Human Prescription Drug

**Active ingredient:** LIRAGLUTIDE

**Strength:** 6 mg/mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Novo Nordisk

**Marketing category:** NDA (NDA022341)

**Pharmacologic class:** GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]